Illumina Inc (ILMN)

163.37
2.07 1.28
NASDAQ : Health Care
Prev Close 161.30
Open 161.30
Day Low/High 161.12 / 163.46
52 Wk Low/High 127.10 / 223.24
Volume 892.45K
Avg Volume 1.31M
Exchange NASDAQ
Shares Outstanding 146.30M
Market Cap 23.60B
EPS 3.10
P/E Ratio 52.54
Div & Yield N.A. (N.A)

Latest News

ILMN SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Illumina, Inc. And A Lead Plaintiff Deadline Of February 14, 2017

ILMN SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Illumina, Inc. And A Lead Plaintiff Deadline Of February 14, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of California on behalf of investors who purchased Illumina, Inc.

Illumina Reports Full Financial Results For Fourth Quarter And Fiscal Year 2016

Illumina Reports Full Financial Results For Fourth Quarter And Fiscal Year 2016

Illumina, Inc. (NASDAQ:ILMN) today announced its full financial results for the fourth quarter and fiscal year 2016.

Illumina Debuts VeriSeq™ Analysis Software (48 Samples), Optimized Data Analysis For Noninvasive Prenatal Testing

Illumina Debuts VeriSeq™ Analysis Software (48 Samples), Optimized Data Analysis For Noninvasive Prenatal Testing

Illumina, Inc. (NASDAQ: ILMN) today announced that it has declared conformity with the requirements of the IVD Directive and has applied the CE mark to an expanded VeriSeq™ NIPT Analysis Software for clinical...

Caroline Dorsa (Photo: Business Wire)

Caroline Dorsa (Photo: Business Wire)

Illumina, Inc. (NASDAQ: ILMN) announced today that Caroline Dorsa has joined the company's Board of Directors.

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Illumina, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of February 14, 2017

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Illumina, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of February 14, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Illumina, Inc.

ILMN SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Illumina, Inc. And A Lead Plaintiff Deadline Of February 14, 2017

ILMN SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Illumina, Inc. And A Lead Plaintiff Deadline Of February 14, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of California on behalf of investors who purchased Illumina, Inc.

Illumina To Announce Fourth Quarter And Fiscal Year 2016 Financial Results On Tuesday, January 31, 2017

Illumina To Announce Fourth Quarter And Fiscal Year 2016 Financial Results On Tuesday, January 31, 2017

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for fourth quarter and fiscal year 2016 following the close of market on Tuesday, January 31, 2017.

Short Interest Moves 16% Higher For ILMN

Short Interest Moves 16% Higher For ILMN

The most recent short interest data has been released for the 12/30/2016 settlement date, which shows a 782,162 share increase in total short interest for Illumina Inc , to 5,653,100, an increase of 16.06% since 12/15/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Does Illumina Have the Genes for Lasting Growth?

Does Illumina Have the Genes for Lasting Growth?

This week's introduction of the NovaSeq Series of genomic sequencers caused the stock to jump.

Illumina, NRGene Collaborate To Accelerate Development Of New Molecular Breeding Tools For Cattle To Support Global Food Production

Illumina, NRGene Collaborate To Accelerate Development Of New Molecular Breeding Tools For Cattle To Support Global Food Production

Illumina, Inc. (NASDAQ: ILMN), the global leader in next-generation sequencing technology, and NRGene, a globally recognized leader in genome assembly and analysis, today announced a collaboration to develop new molecular...

Stocks Mixed Again as Dow Declines but Nasdaq Remains on Track for Record Close

Stocks Mixed Again as Dow Declines but Nasdaq Remains on Track for Record Close

Stocks turn mixed on Tuesday, though the Nasdaq remains on track to set to record a close for its third day in a row.

Stocks Turn Positive, Nasdaq Trades Above Record Closing High

Stocks Turn Positive, Nasdaq Trades Above Record Closing High

Stocks turn higher Tuesday as crude oil declines and the fourth-quarter earnings season draws closer.

Biotech Premarket Movers: ILMN, NSTG, KITE

Biotech Premarket Movers: ILMN, NSTG, KITE

Illumina, NanoString Technologies and Kite Pharma are among the premarket movers in biotech.

IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Illumina, Inc. And Encourages Investors With Losses To Contact The Firm

IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Illumina, Inc. And Encourages Investors With Losses To Contact The Firm

Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Illumina, Inc.

Illumina NovaSeq 6000 System (Photo: Business Wire)

Illumina NovaSeq 6000 System (Photo: Business Wire)

Illumina, Inc. (NASDAQ: ILMN), the global leader in next-generation sequencing technology, today introduced the NovaSeq TM Series, a new and scalable sequencing architecture expected one day to enable a $100 genome.

IBM Seals Genomics Partnership With Illumina

IBM Seals Genomics Partnership With Illumina

Big Blue has teamed up with genomic analysis products company Illumina.

IBM And Illumina Partner To Standardize Genomic Data Interpretation

IBM And Illumina Partner To Standardize Genomic Data Interpretation

Data interpretation from Watson will help users translate genomic data from Illumina TruSight® Tumor 170; offering to be available early in 2017

Philips And Illumina Join Forces To Offer Integrated Genomics Solutions For Oncology

Philips And Illumina Join Forces To Offer Integrated Genomics Solutions For Oncology

Collaboration aims to leverage Illumina's world-class DNA sequencing technology and BaseSpace® Sequence Hub with Philips' innovative cloud-based genomics platform for the acquisition, analysis and interpretation of genomics data in cancer research

Why Surging eBay Could Rip Even Higher

Why Surging eBay Could Rip Even Higher

Here come the gains.

Illumina Tops the Nasdaq 100 -- and Here's How to Trade It

Illumina Tops the Nasdaq 100 -- and Here's How to Trade It

Shares of biotech company Illumina are leading the Nasdaq higher with a surge of more than 4.5% on Friday.

GRAIL Plans To Raise In Excess Of $1B In Series B Funding

GRAIL Plans To Raise In Excess Of $1B In Series B Funding

Illumina, Inc. (NASDAQ: ILMN), today announced that GRAIL has received indications of interest to invest approximately $1B for its Series B financing, primarily from undisclosed private and strategic investors.

Leading Genetic Testing Companies Join Forces To Launch The Coalition For Access To Prenatal Screening

Leading Genetic Testing Companies Join Forces To Launch The Coalition For Access To Prenatal Screening

Coalition aims to make noninvasive prenatal testing easily accessible to all pregnant women

Garret Hampton (Photo: Business Wire)

Garret Hampton (Photo: Business Wire)

Illumina, Inc. (NASDAQ: ILMN), continuing its strategy to bring the power of genomics into clinical applications, today announced it has named one of the world's top clinical genomics experts to head its clinical genomics...